May 234BIO Capital Portfolio Company Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease
Jun 8, 20204BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin
